Physician profile
Victor Benezra
NPI 1235122896
$23,753.91
in general payments reported to CMS, 2019-2025
51 companies · $1,556 in 2025
The $1,556 reported for 2025 was more than what 88% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,953 · 2020: $970 · 2021: $10K · 2022: $5,668 · 2023: $2,029 · 2024: $1,470 · 2025: $1,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,957 · Education: $98.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,956.54 |
| Education | $98.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,984.79 | 2019-2025 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $1,037.44 | 2021-2025 | |
| Exeltis, USA INC. | $860.10 | 2019-2025 | Slynd, Nuvessa, Nuvessa |
| Astellas Pharma US INC | $819.21 | 2021-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $607.22 | 2019-2025 | Novasure, Fluent Fluid Management System, Thinprep 2000 Processor |
| Pfizer INC. | $458.23 | 2019-2025 | |
| Amgen INC. | $395.67 | 2019-2024 | Prolia, Evenity |
| Millicent US INC | $392.56 | 2020-2025 | Intrarosa, Femlyv, Femring |
| Therapeuticsmd, INC. | $389.32 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $296.21 | 2019-2025 | |
| Gynesonics, INC. | $294.93 | 2022 | |
| Sumitomo Pharma America, INC. | $258.19 | 2024-2025 | Myfembree, Gemtesa |
| Lupin INC. | $257.83 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $230.14 | 2020-2023 | Onzetra Xsail, Contrave |
| Organon LLC | $197.48 | 2021-2025 | Nexplanon |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Benezra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.